Education
About Us
Working with TipRanks
Follow Us
Hoyoung Huh Insider Profile
4 Followers
Hoyoung Huh, Director at Geron, holds 154.30K shares in Geron (Ticker: GERN), holds ― shares in CytomX Therapeutics (Ticker: CTMX), holds ― shares in Eidos Therapeutics (Ticker: EIDX).
Hoyoung Huh has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hoyoung Huh holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hoyoung Huh
Hoyoung Huh's Trading History
Geron
Jan 02, 2018
Director
Uninformative Buy
―
$266.94K
CytomX Therapeutics
―
Director
―
―
Eidos Therapeutics
―
―
―
―
Pliant Therapeutics
―
Director
―
$388.18K
Peak Bio
Nov 18, 2024
―
Uninformative Buy
―
$0.00
Akari Therapeutics
Mar 10, 2025
Director, Ten Percent Owner
Uninformative Buy
1000.00K
$4.44M
Nektar Therapeutics
―
Director
―
$7.02K
Rezolute
Apr 09, 2014
Director, Ten Percent Owner
Uninformative Buy
290.87B
―
List of latest transactions for each holding click on a transaction to see Hoyoung Huh's performance on stock
You May Also Like
Hoyoung Huh insider profile FAQ
What is the percentage of profitable transactions made by Hoyoung Huh?
The percentage of profitable transactions made by Hoyoung Huh is ―.
What is the average return per transaction made by Hoyoung Huh?
The average return per transaction made by Hoyoung Huh is ―.
What stocks does Hoyoung Huh hold?
Hoyoung Huh holds: GERN, CTMX, EIDX, PLRX, PKBO, AKTX, NKTR, RZLT stocks.
What was Hoyoung Huh’s latest transaction?
Hoyoung Huh latest transaction was an Uninformative Buy of ―.
What was Hoyoung Huh's most profitable transaction?
Hoyoung Huh’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hoyoung Huh's role in Geron?
Hoyoung Huh's role in Geron is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.